Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Good times ahead

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jul 20, 2022 2:12pm

142 Views

Post# 34837848

RE:Good times ahead

Ontario will be the first province to recommend and cover the treatment, given its investment in TLT's work and the medical tourism opportunity.

Insurance companies in the US will also have a huge incentive to cover such treatment. Public health systems (Canada, Europe, etc ...) will also have huge incentives too to recommend such treatment.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China